Financial reports
ARS
2023 FY
Annual report to shareholders
18 Apr 24
NT 10-K
Notice of late annual filing
1 Mar 24
10-K
2023 FY
Annual report
1 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
5 May 23
ARS
2022 FY
Annual report to shareholders
24 Apr 23
10-K
2022 FY
Annual report
14 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
Current reports
8-K
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
17 Apr 24
8-K
Entry into a Material Definitive Agreement
10 Apr 24
8-K
89bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
29 Feb 24
8-K
Entry into a Material Definitive Agreement
8 Dec 23
8-K
Other Events
6 Dec 23
8-K
Regulation FD Disclosure
4 Dec 23
8-K
Regulation FD Disclosure
27 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
14 Nov 23
8-K
89bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
8 Nov 23
8-K
Departure of Directors or Certain Officers
15 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
7 Mar 24
424B5
Prospectus supplement for primary offering
8 Dec 23
424B5
Prospectus supplement for primary offering
6 Dec 23
S-3ASR
Automatic shelf registration
23 May 23
S-3ASR
Automatic shelf registration
25 Apr 23
424B5
Prospectus supplement for primary offering
27 Mar 23
424B5
Prospectus supplement for primary offering
22 Mar 23
S-8
Registration of securities for employees
15 Mar 23
424B5
Prospectus supplement for primary offering
15 Feb 23
S-3/A
Shelf registration (amended)
10 Feb 23
Proxies
DEFA14A
Additional proxy soliciting materials
17 Apr 24
DEF 14A
Definitive proxy
17 Apr 24
DEFA14A
Additional proxy soliciting materials
24 Apr 23
DEF 14A
Definitive proxy
24 Apr 23
PRE 14A
Preliminary proxy
14 Apr 23
DEFA14A
Additional proxy soliciting materials
14 Apr 22
DEF 14A
Definitive proxy
14 Apr 22
DEFA14A
Additional proxy soliciting materials
15 Apr 21
DEF 14A
Definitive proxy
15 Apr 21
DEFA14A
Additional proxy soliciting materials
8 May 20
Other
EFFECT
Notice of effectiveness
27 Feb 23
EFFECT
Notice of effectiveness
22 Feb 23
CORRESP
Correspondence with SEC
10 Feb 23
UPLOAD
Letter from SEC
1 Feb 23
EFFECT
Notice of effectiveness
26 Apr 21
CORRESP
Correspondence with SEC
21 Apr 21
UPLOAD
Letter from SEC
1 Apr 21
EFFECT
Notice of effectiveness
17 Sep 20
CORRESP
Correspondence with SEC
14 Sep 20
CORRESP
Correspondence with SEC
14 Sep 20
Ownership
3
Martin Babler
23 Apr 24
4
Peter Kolchinsky
15 Apr 24
4
ROHAN PALEKAR
3 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
SC 13D/A
RA CAPITAL MANAGEMENT, L.P.
6 Mar 24
4
Peter Kolchinsky
6 Mar 24
4
ROHAN PALEKAR
28 Feb 24
144
Notice of proposed sale of securities
26 Feb 24
4
Ryan Martins
23 Feb 24
4
ROHAN PALEKAR
23 Feb 24